Reserve your spot today for this Satellite Symposium!

Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.     This activity is supported by an independent educational grant from Sanofi Genzyme. Sunday, May 3, 2020 Registration: 4:00 PM - 4:30 PM Program: 4:30 PM - 6:00 PM Wynn Hotel Room: Bandol 2 (New Wynn Space) Las Vegas, NV Please note: No additional fee is required to attend this CPE activity; however, registration to the Specialty Pharmacy Summit 2020 is required. Due to the recent outbreak of COVID-19, Asembia has made the decision to postpone the Specialty Pharmacy Summit. For more information about this, please visit the Summit's website: www.asembiasummit.com. In the meantime, please visit the Impact Education, LLC ® website for updates regarding this program as well as more free CE opportunities on current specialty pharmacy topics. www.impactedu.net   Top Reasons to Attend Learn where current and emerging therapies fit into the MS management algorithm Find out how the impact of and value of real-world evidence to inform clinical decision making in MS Discover how to integrate electronic health technology into MS care management Know how treatment optimization approaches to balance costs with improved outcomes in MS management   Expert Faculty Presenters Alexis Crispino Director of Education & Healthcare Relations Multiple Sclerosis Association of America (MSAA) Mitzi Joi Williams, MD Assistant Professor of Medicine Clinical Neurologist Morehouse School of Medicine Michael Zeglinski, RPh Senior Vice President, Specialty Pharmacy OptumRx®/BriovaRx®   Who Should Attend? The target audience for this activity consists of specialty pharmacy professionals and other managed care pharmacy professionals attending the Specialty Pharmacy Summit 2020.   Statement of Need/Program Overview More than a dozen disease-modifying therapies (DMTs) are available for the treatment of MS with several additional novel therapies in late stage development. Early diagnosis and aggressive treatment is essential to minimize the MS disease burden and limit use of limited health care resources. Therefore, a high level of disease and therapeutic knowledge is necessary to effectively and efficiently manage the disease. The continually evolving MS treatment landscape accentuates the need for increased disease and therapeutic knowledge amongst managed care and specialty pharmacy professionals in order to optimize clinical outcomes, reduce treatment variability, and increase patient engagement in their own care. This program highlights opportunities for managed care and specialty pharmacy professionals to enhance the management of patients with MS by implementing and/or recommending evidence-driven practices and administrative routines based on current clinical trial data.   Educational Objectives At the conclusion of this activity, participants should be able to demonstrate improved ability to: Discuss where current and emerging therapies fit into the MS management algorithm Review the potential impact of and value of real-world evidence to inform clinical decision making in MS Explore how to integrate electronic health technology into MS care management Employ treatment optimization approaches to balance costs with improved outcomes in MS management   Agenda Date and Time Sunday, May 3, 2020 Registration: 4:00 PM - 4:30 PM Program: 4:30 PM - 6:00 PM Wynn Hotel Room: Bandol 2 (New Wynn Space) Las Vegas, NV 4:30 PM Pre-Activity Learning Assessment and Opening Comments/Overview Michael Zeglinski, RPh 4:35 PM Assessing the Clinical Benefits of Current and Emerging MS Therapies in a Specialty Pharmacy Setting Mitzi Joi Williams, MD 5:05 PM Specialty Pharmacy Management Services for Optimal Outcomes in MS Michael Zeglinski, RPh 5:30 PM Shared Decision-Making: Aligning MS Specialty Pharmacy Care with Patient Needs Alexis Crispino 5:45 PM Audience Q&A Session Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation 6:00 PM Adjournment

Accreditation Statements

Pharmacy Credit Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: 0816-9999-20-118-L01-P This activity is certified as Knowledge-based CPE.

Disclosure of Conflicts of Interest It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Americans with Disabilities Act ♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE activity. Please note: No additional fee is required to attend this CPE activity; however, registration to the Specialty Pharmacy Summit 2020 is required. Pre-registration will close at 12:00 pm on May 2, 2020. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.